Trevi Therapeutics Earnings
NASDAQ: TRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.19+0.365 (+2.85%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 13.19 0.00%
Trevi Therapeutics earnings summary
In its most recent report on Aug 6, 2026 (Q2 2026), TRVI posted EPS of $-0.11. Across the last 16 reports, TRVI shares moved an average of 4.7% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
TRVI earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.11 | — | -0.3% |
| Apr 17, 2026 | — | $-0.09 | — | -5.4% |
| Mar 17, 2026 | — | $-0.06 | — | +6.8% |
| Nov 13, 2025 | — | $-0.08 | — | -3.3% |
| Aug 7, 2025 | — | $-0.09 | — | +1.3% |
| May 8, 2025 | — | $-0.09 | — | -1.5% |
| Jan 8, 2025 | — | $-0.11 | — | -1.6% |
| Nov 6, 2024 | — | $-0.13 | — | -5.5% |
| Aug 8, 2024 | — | $-0.12 | — | -3.1% |
| May 7, 2024 | — | $-0.11 | — | +1.5% |
| Mar 20, 2024 | — | $-0.08 | — | -3.9% |
| Nov 9, 2023 | — | $-0.08 | — | +6.1% |
| Aug 10, 2023 | — | $-0.07 | — | -9.7% |
| May 11, 2023 | — | $-0.06 | — | -15.2% |
| Mar 16, 2023 | — | $0.05 | — | +0.6% |
| Nov 10, 2022 | — | $-0.12 | — | +9.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.